PATENT CLAIM ANALYSIS

Application Number: 16374461
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-11
Patent Classification: ["514", "043000"]

Abstract:
The present invention relates to inorganic salts of nicotinic acid mononucleotides and compositions of Formula I, useful in the treatment of disorders and diseases associated with deficiencies in NAD + : wherein A, M 1 , M 2 , k, R 1 , R 2 , and R 3  are as described herein.

Claim (Index 1):
A salt of Formula (I): or enantiomer, stereoisomer, or tautomer thereof, wherein\n A is O \u2212 ; \n M 1  and M 2  are independently alkali metal or alkaline earth metal; \n R 1  and R 2  are independently H or (C 0 -C 3 alkylene)C(O)C 1 -C 6 alkyl; \n R 3  is a negative charge or H; k is 1; and \n provided that when R 3  is H, then M 1  is absent.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 100.0
- Lexical Diversity: 1.39024
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15492952', '15461126', '15072121', '15809731', '15562336']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7254627650511459
- 35 USC 102 Novelty (BERT): 0.5024725625358542
- Combined Prediction Score: 0.7031637447996167
- Mean Citation Score: 196.587488
- Max Citation Score: 208.45897
- Similarity Product: 143.06077715593815

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test